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‘exchange sex for drugs and money’, and seems to suggest that
the use of quantitative scales was inappropriate in this study.
We agree with the truism that quantitative research has its
limitations, and that behavioural scales should be used with
due caution.  We would, however, emphasise that given that
HIV/AIDS is currently the most important contributor to
South Africa’s burden of disease, quantitative research to
ascertain its behavioral antecedents, associations, and
consequences is of paramount importance.  Such antecedents
undoubtedly include transactional sex between men and
women.4 The instruments used in our study were appropriate
for its focused objectives, although future work to provide
additional information on their psychometrics in the local
context would certainly be valuable.
This is an opportune time to correct an error in the paper —
the Brief Cope was described as a 12-scale measure, but is in
fact a 14-scale instrument.
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Ventricular fibrillation in a
clinically normal heart
To the Editor: The recent scientific letter by Stanley1 reports on
an interesting case of idiopathic electrical cardiac disorder —
ventricular fibrillation — in a patient with normal heart
anatomy and haemodynamic functions. Idiopathic (or
‘primary’) ventricular fibrillation remains an enigma although
over the last decades significant advances have been made in
understanding the causes and mechanisms in some subgroups
of patients.2
Brugada syndrome is one of the conditions recently
recognised and defined at clinical and cellular levels.
Polymorphic ventricular tachycardia or fibrillation in patients
with Brugada syndrome who have normal heart anatomy is
initiated by so-called phase 2 (of monophasic action potential)
re-entry among different layers of myocardium (epi-, mid-, and
endocardial), which occurs due to an abnormal function of
cellular membrane sodium channel SNCA5.3
Unfortunately, the diagnosis of Brugada syndrome in the
reported patient is based solely on surface ECG patterns that
are equivocal. There is no real ST-segment elevation in right
precordial leads and the partial right bundle-branch block has
a narrow r’ wave while the typical r’ wave should be wider
and part of a saddle-back pattern (www.crtia.be). The surface
electrocardiogram in Brugada syndrome can be variable;
therefore, pharmacological testing using class I antiarrhythmic
drugs is recommended to uncover or highlight abnormal
patterns. In the presented case, neither pharmacological nor
genetic testing was performed. The easy induction of
ventricular fibrillation during electrophysiological study was
also a nonspecific finding possibly suggesting an electrical
vulnerability but not confirming the diagnosis of Brugada
syndrome.
In conclusion, Stanley presents an interesting case of
idiopathic ventricular fibrillation that was appropriately
managed by implantation of a cardioverter/defibrillator, and
that underlines the significance of ICD for secondary
prevention in cardiac arrest survivors and in patients with
symptomatic ventricular tachycardias.4
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Traditional formulary?
To the Editor: I see the HPCSA wants to register traditional
healers, thereby ensuring better control and that medical aids
will then also pay for their services. I wonder, will they be able
to dispense traditional medicines as they have done for many
years, and will these medicines be specified in a formulary? If
they are allowed to dispense medicines, why is this different
from Western-trained doctors?
I would be interested to hear what other doctors think. By
the way, I am not a dispensing doctor.
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